TrialViruses2024

No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials.

Charlotte Hedskog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.